JAPMA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bernard, J. M.
Right arrow Articles by Covey, D. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bernard, J. M.
Right arrow Articles by Covey, D. F.

Journal of the American Podiatric Medical Association, Vol 82, Issue 7 345-351, Copyright © 1992 by American Podiatric Medical Association

JOURNAL ARTICLE

Warfarin sodium. Practitioner beware

JM Bernard, JR Black, CU Kokseng and DF Covey
J.A. Haley Veterans Hospital, Tampa, FL.

The use of warfarin sodium in the US has increased dramatically over the last 40 years. Warfarin sodium or Coumadin is the most popular oral anticoagulant used in the US. The podiatric physician frequently encounters patients taking this agent and therefore needs to understand its potential impact. This article will familiarize the reader with the history, pharmacology, clinical applications, side effects, and frequent drug interactions encountered with warfarin sodium.


This article has been cited by other articles:


Home page
 CLIN APPL THROMB HEMOSTHome page
V. Wiwanitkit
Pharmacogenomic Effect of Cytochrome P450 2C9 Polymorphisms in Different Populations
Clinical and Applied Thrombosis/Hemostasis, April 1, 2006; 12(2): 219 - 222.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American Podiatric Medical Association.